Ankit Tomar, MD
Adjunct Professor
Biography
Dr. Ankit Tomar is an ophthalmologist specializing in ocular oncology, with advanced fellowship training in the diagnosis and treatment of cancers of the eye and surrounding structures. Originally from India, he completed medical school, ophthalmology residency, and a fellowship in ocular oncology and oculoplastics before pursuing additional advanced fellowship training in New York under the mentorship of Dr. Paul T. Finger, an internationally recognized leader and pioneer in ophthalmic oncology.
At Tulane University, Dr. Tomar works alongside Dr. Finger to establish a premier Ocular Oncology Service dedicated to serving patients throughout Louisiana and the Gulf South. Combining Dr. Finger's decades of pioneering clinical experience and innovation with Dr. Tomar's extensive subspecialty training and research expertise, they are developing a comprehensive center for the diagnosis and treatment of eye cancer. The program integrates state-of-the-art diagnostic imaging, innovative radiation therapies, advanced surgical techniques, and multidisciplinary care. Their shared vision is to establish Tulane as a regional destination for eye cancer treatment, bringing highly specialized expertise and innovative therapies closer to patients who previously had limited access to such care.
Beyond his clinical expertise, Dr. Tomar has emerged as an international leader in ophthalmic oncology research and cancer staging. He played a pivotal role in the American Joint Committee on Cancer (AJCC) international retinoblastoma registry, which brought together more than 2,100 patients from 18 centers across 13 countries and six continents. This landmark collaboration produced eight peer-reviewed publications in Ophthalmology, advancing the understanding of retinoblastoma prognosis and validating international cancer staging systems. In recognition of his contributions, Dr. Tomar was selected to chair the AJCC's Retinoblastoma Committee for the ninth edition of its cancer staging system, helping shape how this childhood eye cancer is classified and studied worldwide.
Dr. Tomar is committed to providing compassionate, individualized care guided by four fundamental goals: curing cancer, preserving vision, saving the eye whenever possible, and protecting quality of life. Through his dedication to patient care, international collaboration, research, and education, he is helping establish Tulane as a center of excellence in ophthalmic oncology while advancing the future of eye cancer care throughout the Gulf South and beyond.